Petition Pressure NICE to approve nivolumab to treat advanced Kidney Cancer

Nivolumab has shown great promise in the treatment of kidney cancer. Following the 1st meeting to review the clinical trial evidence & cost-effectiveness of Nivolumab in treating kidney cancer, NICE has said it's unlikely they'll recommend the drug for this area. This stance needs reversing.

More details

In 2013, more than 11,800 people were diagnosed with kidney cancer; that's about 33 people each day. It is now the seventh most common cancer in the UK: the fifth most common cancer in men and the tenth in women. Since the late 1970s, kidney cancer incidence rates have more than doubled in Great Britain. With rising numbers each year, Nivolumab could make a huge difference to many people's lives.

This petition is closed This petition ran for 6 months

5,195 signatures

Show on a map

10,000

Date closed 18 January 2017
Get petition data (json format)

About petition data

The data shows the number of people who have signed the petition by country as well as in the constituency of each Member of Parliament. This data is available for all petitions on the site. It is not a list of people who have signed the petition. The only name that is shared on the site is that of the petition creator.